The venture was found in Europe in Norway. The main office of represented VC is situated in the Oslo.
The top activity for fund was in 2010. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are SPRINGfondet, Medinnova.
Among the most popular portfolio startups of the fund, we may highlight Setred.com. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Norway. Among the most popular fund investment industries, there are Industrial, 3D Technology.
Fund Name | Location |
BioCanRx | Canada, Ontario, Ottawa |
Choice Capital Partners | - |
D2M | California, Sunnyvale, United States |
Doorway Capital | England, London, United Kingdom |
DW Fund | China, Shanghai, Xuhui |
Equilibra Partners Management | New York, New York, United States |
Globant | Chicago, Illinois, United States |
Ludlow Ventures | Detroit, Michigan, United States |
Matuca | Luxembourg, Luxembourg |
Meridian Street Capital | New York, New York, United States |
Northgate Capital | California, Danville, United States |
Ocean Azul Partners | Florida, Miami, United States |
OneBeacon Insurance Group | Bermuda, Hamilton |
PineCypress Fund | Beijing, Beijing, China |
Qianshi Investment | China, Shanghai |
Russia-Japan Investment Fund | - |
Stanford Financial Group | Houston, Texas, United States |
Startupbootcamp InsurTech London | England, London, United Kingdom |
Tamarace | China, Guangdong, Shenzhen |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.